Elsevier

World Neurosurgery

Volume 82, Issues 1–2, July–August 2014, Pages 240.e7-240.e12
World Neurosurgery

Peer-Review Short Report
Surgically Induced SMART Syndrome: Case Report and Review of the Literature

https://doi.org/10.1016/j.wneu.2013.01.028Get rights and content

Background

Strokelike migraine attack after radiation therapy is a recently described clinical entity characterized by transient hemispheric dysfunction manifesting as, but not limited to, visuospatial deficits, confusion, hemisensory deficits, hemiparesis, aphasia, seizures, and, most prominently, headache in patients with a history of remote external beam radiation therapy to the brain. The radiographic hallmark on magnetic resonance imaging is the presence of transient, diffuse, unilateral gadolinium enhancement of the cortex with white matter sparing, usually corresponding to the previous radiation field.

Case Description

We present a case of strokelike migraine attacks after radiation therapy syndrome diagnosed immediately following a craniotomy and temporal lobectomy for recurrent metastatic tumor resection after prior gamma knife radiosurgery and whole-brain radiation therapy.

Conclusion

SMART syndrome should be considered in the differential diagnosis of postsurgical patients with remote history of cranial irradiation and significant, new transient neurologic deficits not explainable by any other mechanism. It is possible that manipulation of the trigeminal ganglion, or the dura of the Meckel cave, contributed to triggering the manifestations of this syndrome in our patient during the immediate postoperative period.

Section snippets

Clinical Presentation

A 56-year-old right-handed woman presented in April 2005 with a history of stage 4 infiltrating adenocarcinoma of the right breast. At the time of diagnosis she was also discovered to have lung metastases. Following lumpectomy, she was treated with paclitaxel (Taxol), followed by six cycles of docetaxel (Taxotere) and trastuzumab (Herceptin). She was then maintained on trastuzumab and letrozole (Femara). She responded well and her malignancy was considered to be in remission by February 2006.

In

Discussion

The SMART syndrome was first described by Bartleson et al. in two patients with prior history of radiation therapy (RT) (2). They later proposed the diagnostic criteria listed in Table 1 (3). To date, there have been 25 suspected cases described in the literature (articles restricted to English); 8 women and 17 men (Tables 2 and 3) 2, 3, 4, 5, 11, 16, 18, 19, 21. None of them have been temporarily related or attributed to recent intracranial surgery, although many cases have history of prior

Conclusion

This is the first report of a case of SMART syndrome occurring in the acute postoperative period after an uncomplicated neurosurgical procedure. SMART syndrome should be considered in the differential diagnosis of postsurgical patients with remote history of cranial irradiation and significant, new transient neurologic deficits not explainable by any other mechanism. It is possible that manipulation of the trigeminal ganglion, or the dura of the Meckel cave, contributed to triggering the

References (26)

  • M.G. Gephart et al.

    Perioperative posterior reversible encephalopathy syndrome in 2 pediatric neurosurgery patients with brainstem ependymoma

    J Neurosurg Pediatr

    (2011)
  • E.A. Giraldo et al.

    Posterior reversible encephalopathy syndrome associated with hemodynamic augmentation in aneurysmal subarachnoid hemorrhage

    Neurocrit Care

    (2011)
  • J.P. Kerklaan et al.

    SMART syndrome: a late reversible complication after radiation therapy for brain tumours

    J Neurol

    (2011)
  • Cited by (17)

    • SMART syndrome

      2021, Neurologia
    • Uncommon radiation-induced neurological syndromes

      2020, Neuro-Oncology for the Clinical Neurologist
    • Stroke-like migraine attacks after radiation therapy syndrome: a case report and literature review

      2017, Radiology Case Reports
      Citation Excerpt :

      For long-term prophylaxis of episodes of SMART syndrome, aspirin and verapamil have been used to good effect [3,4,10–12]. The efficacy of steroids has shown mixed results [5,13,14]. Although initially described as a temporary or reversible condition, a recent case series [5] demonstrated that reversibility is not universal, with nearly half of cases showed incomplete resolution.

    • Strategies to improve the quality of survival for childhood brain tumour survivors

      2015, European Journal of Paediatric Neurology
      Citation Excerpt :

      CRT-related LE range from transient and treatable to permanent and progressive impairments.86 The risk of many LE is, as shown in Table 2,87–145 dependent of CRT-region, -dose, -technique and multiple covariates. The role of the CRT-dose-volume-ratio still needs validation for already examined entities such as ependymoma and LGG70,146 and also further analysis for other CBT-subgroups and different CRT techniques.

    View all citing articles on Scopus

    Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    View full text